About Index Trending news
Analyze
Top 50 Pricing
Apellis Pharma

Apellis Pharma

Work at Apellis Pharma? Add yourself to this profile

Apellis Pharma

Small Biotech Focusing on Complement Immunotherapy

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series D)
$47,100,000
Hillhouse Capital Group, Epidarex Capital, Cormorant Asset Management, +3
Venture capital (Series D)
$32,000,000
Employees

Unknown size

Locations
HQ
Headquarters
$47,100,000 Venture capital (Series D)
FinSMEs

Apellis Pharmaceuticals Completes $47.1M Series D Financing

Health Funding
$32,000,000 Venture capital (Series D)
venturedeal

Apellis Pharma Accepts $32 Million Equity VC